Sustainability of Rituximab Therapy in Different Treatment Strategies: Results of a 3-Year Followup of a German Biologics Register

OBJECTIVE: To compare the approved treatment of rheumatoid arthritis using rituximab + methotrexate (RTX + MTX) versus the off-label treatment variants of RTX in monotherapy or RTX in combination with leflunomide (RTX + LEF). METHODS: We included RTX-naive patients enrolled in the German biologics r...

Descripción completa

Detalles Bibliográficos
Autores principales: Richter, Adrian, Strangfeld, Anja, Herzer, Peter, Wilden, Elke, Bussmann, Arnold, Listing, Joachim, Zink, Angela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282041/
https://www.ncbi.nlm.nih.gov/pubmed/24664818
http://dx.doi.org/10.1002/acr.22327

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282041/
https://www.ncbi.nlm.nih.gov/pubmed/24664818
http://dx.doi.org/10.1002/acr.22327

Ejemplares similares